United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Soleno Therapeutics as the specialty pharmacy ...

PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to ...

Lobbyist Danny Thompson, representing the Pharmaceutical Industry Labor and Management Association (PILMA), said PBMs in ...

BofA lowered the firm’s price target on United Therapeutics (UTHR) to $314 from $328 and keeps an Underperform rating on the shares. The firm ...

In this article, we are going to take a look at where Protagonist Therapeutics, Inc. (NASDAQ ... this pattern is very common. Simply said, the United States lacks the infrastructure to handle the ...

Fate Therapeutics, Inc. (NASDAQ:FATE – Free Report) – Equities research analysts at Wedbush raised their Q1 2025 earnings per share (EPS) estimates for Fate Therapeutics in a research note ...

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...

Manchester United will return to the US for pre-season preparations this July and August, as part of the Premier League’s Summer Series. The announcement of United’s participation in the ...

Axsome Therapeutics has entered into a settlement ... The litigation, which is pending in the United States District Court for the District of New Jersey, resulted from submission by Hikma of ...